PRODUCT DETAIL

Bilastin STADA 20 mg tablety

Code

1776E

MA number

24/0222/22-S

Product Form:

tbl 50x20 mg (blis.Al/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Mutual recognition procedure

MAH, country:

STADA Arzneimittel AG, Germany

Therapeutic Class:

24 - ANTIHISTAMINICA, HISTAMIN

ATC:

R	RESPIRATORY SYSTEM
R06	ANTIHISTAMINES FOR SYSTEMIC USE
R06A	ANTIHISTAMINES FOR SYSTEMIC USE
R06AX	Other antihistamines for systemic use
R06AX29	Bilastine

Shelf life:

Container:

blister Al/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	06.09.2022
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
SPC:	SPC_Bilastin STADA 20 mg tablety_04/2025.pdf
PIL:	PIL_Bilastin STADA 20 mg tablety_OTC_04/2025.pdf
PIL:	PIL_Bilastin STADA 20 mg tablety_Rx_04/2025.pdf
Safety feature	Yes
Data update:	19.11.2025